RY(RY)
RY
Q3 2026 EPS Estimate
$2.87
Aug 27, 2026 · Reports before open
Revenue Estimate
$12.71B
FY2026E EPS$15.39
FY2027E EPS$16.83
Analyst Sentiment
Wall St. Consensus
Hold28 analysts·High coverage
61
Score
13 Buy (46%)14 Hold (50%)1 Sell (4%)
Rating Breakdown
Strong Buy
00%
Buy
1346%
Hold
1450%
Sell
14%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$225.00
+8.7%
Consensus
$225.00
+8.7%
Bull
$225.00
+8.7%
12-Month Target Range28 analysts
$225.00$225.00$225.00
Current $206.97Consensus
Current Price
$206.97
Upside to Consensus
$18.03
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+4.62%
EPS+9.34%
FY2028
Rev+5.62%
EPS+8.23%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $68.60B | $71.76B | $75.79B |
| Low | $68.29B | $71.31B | $74.76B |
| High | $69.01B | $72.10B | $76.91B |
| EBITDA Avg | $17.94B | $18.77B | $19.82B |
| Low | $17.86B | $18.65B | $19.55B |
| High | $18.05B | $18.86B | $20.11B |
| EBIT Avg | $15.82B | $16.55B | $17.48B |
| Low | $15.75B | $16.45B | $17.24B |
| High | $15.92B | $16.63B | $17.74B |
| Net Income Avg | $21.54B | $23.69B | $25.69B |
| Low | $21.17B | $23.52B | $25.22B |
| High | $21.91B | $23.86B | $26.17B |
| EPS Avg | $15.39 | $16.83 | $18.21 |
| Low | $15.02 | $16.68 | $17.89 |
| High | $15.54 | $16.92 | $18.56 |
| Analysts (Rev / EPS) | 7 / 7 | 7 / 8 | 2 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $17.26B | $17.43B | $17.68B | $17.50B | $18.19B | $18.29B | $18.63B | $18.56B |
| Low | $17.17B | $17.34B | $17.58B | $17.41B | $18.09B | $18.19B | $18.53B | $18.47B |
| High | $17.42B | $17.59B | $17.84B | $17.66B | $18.36B | $18.46B | $18.80B | $18.73B |
| EBITDA Avg | $4.52B | $4.56B | $4.62B | $4.58B | $4.76B | $4.78B | $4.87B | $4.86B |
| Low | $4.49B | $4.54B | $4.60B | $4.55B | $4.73B | $4.76B | $4.85B | $4.83B |
| High | $4.56B | $4.60B | $4.67B | $4.62B | $4.80B | $4.83B | $4.92B | $4.90B |
| EBIT Avg | $3.98B | $4.02B | $4.08B | $4.04B | $4.20B | $4.22B | $4.30B | $4.28B |
| Low | $3.96B | $4.00B | $4.06B | $4.01B | $4.17B | $4.20B | $4.27B | $4.26B |
| High | $4.02B | $4.06B | $4.11B | $4.07B | $4.23B | $4.26B | $4.34B | $4.32B |
| Net Income Avg | $3.96B | $4.00B | $4.21B | $4.16B | $4.41B | $4.45B | $4.59B | $4.55B |
| Low | $3.93B | $3.95B | $4.18B | $4.13B | $4.38B | $4.41B | $4.56B | $4.52B |
| High | $3.97B | $4.04B | $4.26B | $4.21B | $4.46B | $4.50B | $4.65B | $4.61B |
| EPS Avg | $3.86 | $3.90 | $4.09 | $4.05 | $4.29 | $4.33 | $4.47 | $4.43 |
| Low | $3.83 | $3.84 | $4.07 | $4.02 | $4.26 | $4.30 | $4.44 | $4.40 |
| High | $3.87 | $3.94 | $4.14 | $4.10 | $4.34 | $4.38 | $4.52 | $4.48 |
| Analysts (Rev / EPS) | 2 / 7 | 2 / 6 | 1 / 2 | 1 / 2 | 1 / 2 | 1 / 2 | 1 / 4 | 1 / 4 |